Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen

The liver has unique microenvironment which is known to induce tolerance of cytolytic CD8+ T cells to hepatic and extra hepatic antigens, resulting in persistence of infection of the liver by the hepatitis B and C viruses. However, under some conditions, functional immune responses can be elicited...

Full description

Bibliographic Details
Main Authors: Mohamed Labib Salem, Randa E. El Naggar, Sabry A. El Naggar, Maysa A. Mobasher, Mohamed H. Mahmoud, Gamal Badr
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2017-12-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
OVA
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1244
id doaj-167b79d2c10245ed8de1171e54a0b038
record_format Article
spelling doaj-167b79d2c10245ed8de1171e54a0b0382020-11-25T04:12:31ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492017-12-011661244Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding AntigenMohamed Labib Salem0Randa E. El Naggar1Sabry A. El Naggar2Maysa A. Mobasher3Mohamed H. Mahmoud4Gamal Badr5Immunology and Biotechnology Unit, Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt AND Center of Excellence in Cancer Research, Tanta University, Tanta, EgyptImmunology and Biotechnology Unit, Department of Zoology, Faculty of Science, Tanta University, Tanta, EgyptImmunology and Biotechnology Unit, Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt AND Center of Excellence in Cancer Research, Tanta University, Tanta, EgyptBiochemistry Division, Department of Pathology, College of Medicine, Aljouf University, Sakaka, Saudi Arabia AND Department of Clinical Pathology, El Ahrar Educational Hospital, Ministry of Health, Zagazig, EgyptDeanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia AND Food Science and Nutrition Department, National Research Center, Dokki, Cairo, EgyptLaboratory of Immunology and Molecular Biology, Zoology Department, Faculty of Science, Assiut University, Assiut, Egypt The liver has unique microenvironment which is known to induce tolerance of cytolytic CD8+ T cells to hepatic and extra hepatic antigens, resulting in persistence of infection of the liver by the hepatitis B and C viruses. However, under some conditions, functional immune responses can be elicited in the liver in particular to show preferential retention of activated CD8+ T cells. It is not clear whether this retention depends on the type of the exogenous immunostimulatory or the endogenous innate immune cells. The T cell receptor (TCR) transgenic OT-1 (CD8+) mouse model was used in which OT-1 cells were harvested from the spleen of the donor and transferred into recipient mice followed by immunization with OVA peptide followed by injection of GM-CSF, CCL21 chemokine, or cytokines (IL-2, IL-12, or IL-15), or the toll-like receptor 3 agonist poly(I:C). Co-administration of any of these immunostimulatory agents relatively augmented the retention of CD8+ T cells with different levels of effects. Compared to spleen, the Ag-specific CD8+ T cells in the liver showed higher activities including expansion, proliferation, apoptosis and memory responses as well as cytolytic function. While depletion of natural killer cells significantly decreased the hepatic retention of the antigen-specific T cells, depletion of Kupffer cells showed opposite effect. Taken together, the antigen reactive T cells in the liver have higher activities than their counterparts in the peripheral tissues such as spleen. These data have important clinical implications for designing immunotherapeutic protocols toward the liver diseases. https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1244CD8 cyclophosphamideKupffer cellsNatural killer cellsOvalbumin-specific OT-IOVAPoly(I
collection DOAJ
language English
format Article
sources DOAJ
author Mohamed Labib Salem
Randa E. El Naggar
Sabry A. El Naggar
Maysa A. Mobasher
Mohamed H. Mahmoud
Gamal Badr
spellingShingle Mohamed Labib Salem
Randa E. El Naggar
Sabry A. El Naggar
Maysa A. Mobasher
Mohamed H. Mahmoud
Gamal Badr
Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen
Iranian Journal of Allergy, Asthma and Immunology
CD8 cyclophosphamide
Kupffer cells
Natural killer cells
Ovalbumin-specific OT-I
OVA
Poly(I
author_facet Mohamed Labib Salem
Randa E. El Naggar
Sabry A. El Naggar
Maysa A. Mobasher
Mohamed H. Mahmoud
Gamal Badr
author_sort Mohamed Labib Salem
title Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen
title_short Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen
title_full Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen
title_fullStr Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen
title_full_unstemmed Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen
title_sort higher activities of hepatic versus splenic cd8+ t cells in responses to adoptive t cell therapy and vaccination of b6 mice with mhc class-1 binding antigen
publisher Tehran University of Medical Sciences
series Iranian Journal of Allergy, Asthma and Immunology
issn 1735-1502
1735-5249
publishDate 2017-12-01
description The liver has unique microenvironment which is known to induce tolerance of cytolytic CD8+ T cells to hepatic and extra hepatic antigens, resulting in persistence of infection of the liver by the hepatitis B and C viruses. However, under some conditions, functional immune responses can be elicited in the liver in particular to show preferential retention of activated CD8+ T cells. It is not clear whether this retention depends on the type of the exogenous immunostimulatory or the endogenous innate immune cells. The T cell receptor (TCR) transgenic OT-1 (CD8+) mouse model was used in which OT-1 cells were harvested from the spleen of the donor and transferred into recipient mice followed by immunization with OVA peptide followed by injection of GM-CSF, CCL21 chemokine, or cytokines (IL-2, IL-12, or IL-15), or the toll-like receptor 3 agonist poly(I:C). Co-administration of any of these immunostimulatory agents relatively augmented the retention of CD8+ T cells with different levels of effects. Compared to spleen, the Ag-specific CD8+ T cells in the liver showed higher activities including expansion, proliferation, apoptosis and memory responses as well as cytolytic function. While depletion of natural killer cells significantly decreased the hepatic retention of the antigen-specific T cells, depletion of Kupffer cells showed opposite effect. Taken together, the antigen reactive T cells in the liver have higher activities than their counterparts in the peripheral tissues such as spleen. These data have important clinical implications for designing immunotherapeutic protocols toward the liver diseases.
topic CD8 cyclophosphamide
Kupffer cells
Natural killer cells
Ovalbumin-specific OT-I
OVA
Poly(I
url https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1244
work_keys_str_mv AT mohamedlabibsalem higheractivitiesofhepaticversusspleniccd8tcellsinresponsestoadoptivetcelltherapyandvaccinationofb6micewithmhcclass1bindingantigen
AT randaeelnaggar higheractivitiesofhepaticversusspleniccd8tcellsinresponsestoadoptivetcelltherapyandvaccinationofb6micewithmhcclass1bindingantigen
AT sabryaelnaggar higheractivitiesofhepaticversusspleniccd8tcellsinresponsestoadoptivetcelltherapyandvaccinationofb6micewithmhcclass1bindingantigen
AT maysaamobasher higheractivitiesofhepaticversusspleniccd8tcellsinresponsestoadoptivetcelltherapyandvaccinationofb6micewithmhcclass1bindingantigen
AT mohamedhmahmoud higheractivitiesofhepaticversusspleniccd8tcellsinresponsestoadoptivetcelltherapyandvaccinationofb6micewithmhcclass1bindingantigen
AT gamalbadr higheractivitiesofhepaticversusspleniccd8tcellsinresponsestoadoptivetcelltherapyandvaccinationofb6micewithmhcclass1bindingantigen
_version_ 1724415261020258304